In rodents, the formation of ovarian follicles occurs after birth. In recent years, several factors required for follicular assembly and the growth of the newly formed follicles have been identified. We now describe a novel gene, Fxna, identified by differential display in the neonatal rat ovary. Fxna encodes an mRNA of 5.4 kb, and a protein of 898 amino acids. Fxna is a transmembrane metallopeptidase from family M28, localized to the endoplasmic reticulum. In the ovary, Fxna mRNA is expressed in granulosa cells; its abundance is maximal 48 hours after birth, i.e. during the initiation of follicular assembly. Reducing Fxna mRNA levels via lentiviral-mediated delivery of short hairpin RNAs to neonatal ovaries resulted in substantial loss of primordial, primary and secondary follicles, and structural disorganization of the ovary, with many abnormal follicles containing more than one oocyte and clusters of somatic cells not associated with any oocytes. These abnormalities were not attributable to either increased apoptosis or decreased proliferation of granulosa cells. The results indicate that Fxna is required for the organization of somatic cells and oocytes into discrete follicular structures. As an endoplasmic reticulum-bound peptidase, Fxna may facilitate follicular organization by processing precursor proteins required for intraovarian cell-to-cell communication.
INTRODUCTION
In recent years, substantial progress has been made towards the identification of genes controlling the assembly and initial growth of ovarian follicles. Along the developmental pathway leading to the formation of ovarian follicles, three genes have been shown to play crucial roles in specifying the fate of germ cells: bone morphogenetic protein 4 (Bmp4), required for the generation of germ cells in the primitive epiblast (Lawson et al., 1999) , stem cell factor (SCF) necessary for germ cell survival during migration towards the genital ridge (Godin et al., 1991) , and wingless-related MMTV integration site 4 (Wnt4), a member of the Wnt family of locally acting cell signals, which is required for intragonadal survival of newly formed oocytes (Vainio et al., 1999) . The formation of primordial follicles requires a transcription factor termed factor in the germline alpha (FIG␣) (Liang et al., 1997) . Subsequent differentiation and growth of primordial follicles is regulated by several factors produced locally by either granulosa cells or the oocyte itself. Granulosa cell factors that facilitate follicle growth include the kit ligand KL (Kitl) (Huang et al., 1993; Parrott and Skinner, 1999) , basic fibroblast growth factor (bFGF; also known as Fgf2) (Nilsson et al., 2001) , leukemia inhibitory factor (Lif) (Nilsson et al., 2002) , the neurotrophins nerve growth factor (NGF), neurotrophin-4/5 (NT-4/5; also known as Ntf5), and brain-derived neurotrophic factor (Bdnf) (Dissen et al., 2001; Paredes et al., 2004; Spears et al., 2003) , and others (Skinner, 2005) . Oocyte factors implicated in the control of follicular growth include: growth differentiation factor 9 (Gdf9) (Dong et al., 1996) , the homeobox gene Nobox (newborn ovary homeobox-encoding gene) (Rajkovic et al., 2004; Suzumori et al., 2002 ) and the TrkB receptors, which are high-affinity tyrosine kinase receptors for NT-4/5 and Bdnf (Paredes et al., 2004; Spears et al., 2003) .
Identification of these key molecules has made it evident that follicular assembly, and the subsequent initiation of gonadotropinindependent follicular growth, require not only genes necessary for the specific development of germ and somatic cells, but also genes that promote and maintain the structural organization of the gland. We have now identified a gene that appears to be required for the structural organization of the rodent ovary. This gene, which we have termed Felix-ina (Fxna), encodes a novel member of the M28 family of metallopeptidases (Rawlings and Barrett, 1995) . Our results suggest that Fxna plays a crucial role in processing proteins required for the organization of somatic cells and oocytes into follicular structures. A partial report of these findings has appeared in an abstract form (Garcia-Rudaz et al., 2004) .
MATERIALS AND METHODS

Animals and tissues
Timed-pregnant Sprague-Dawley rats were purchased from B and K Universal (Fremont, CA). The ovaries were collected from fetuses at 21 days of gestation (F21), at different early postnatal (PN) ages (24, 48, 96 and 144 hours) , PN-day 21, and from 60-to 90-day-old adult rats. In one study, other tissues were collected from PN-48-hour female rats for northern blot analysis. Upon collection, tissue samples were either frozen on dry ice for RNA extraction, or were fixed in either Bouin's fixative for paraffin embedding or in 4% paraformaldehyde-borate buffer, pH 9.5, for in situ hybridization. The rats were maintained and experimental procedures conducted in accordance with the principles outlined in the National Research Council's Guide for the Care and Use of Laboratory Animals under a protocol approved by the ONPRC Animal Care and Use Committee.
RNA isolation
Total RNA was extracted using the acid-phenol method (Chomczynski and Sacchi, 1987) for use in the gene differential display and RNase-protection assays, or using TRI Reagent (Molecular Research Center, Cincinnati, OH) (Mungenast and Ojeda, 2005) for use in all other procedures.
Gene differential display
For identification of genes differentially expressed at the time of follicular assembly we used a Differential Display Kit (GeneHunter, Nashville, TN), as described (Paredes et al., 2005) . The sequences obtained were compared with gene sequences available in GenBank using the Basic Local Alignment Search Tool (BLAST) algorithm applied to searches of the non-redundant (nr) and Expressed Sequence Tag (EST) NCBI databases.
RNase-protection assay and cRNA probes
RNase-protection assays (Gilman, 1993) were carried out as described previously Ma et al., 1996) using 10 g total RNA per tube. Cyclophilin mRNA, which is constitutively expressed in the ovary, was used to normalize Fxna mRNA values. The antisense RNA probes used to detect Fxna transcripts were transcribed from two DNA templates derived from the coding region of Fxna mRNA (probe A, 292 nt, complementary to nt 4846-5138 in NM_184050; probe B, 488 nt, complementary to nt 1591-2079). The cyclophilin probe (158 nt) is complementary to nt 265-422 of rat cyclophilin mRNA (M19533).
Northern blots
Polyadenylated RNA was isolated from total RNA extracted from various tissues of 2-day-old female rats using the MicroPolyA-Purist Kit (Ambion, Austin, TX). Northern blotting was performed as described (Lara et al., 1990; Trzeciak et al., 1987) , using 5 g of mRNA per lane.
In situ hybridization
The in situ hybridization procedure employed (Simmons et al., 1989) was carried out as previously reported (Dissen et al., 1991; Dissen et al., 1995) using 14 m cryostat sections and Fxna cRNA probe A labeled with 35 S-UTP. Control sections were hybridized to a sense Fxna probe transcribed from the same cDNA template but in the opposite direction.
PCR cloning
To sequence Fxna mRNA, we PCR-amplified overlapping portions of the mRNA from ovarian RNA beginning from the 3Ј end using, as a starting point, the sequence of the C5-530a2 cDNA identified by gene differential display. The primers used are listed in Table 1 .
The coding region of Fxna mRNA was cloned using the FailSafe PCR System Kit (Epicentre Biotechnologies, Madison, WI) and primers (forward, 5Ј-TATAGATCTTGGAGTGGAGCTCGGAAGT-3Ј; reverse, 5Ј-TAT -AGATCTTTAAAACACAAAGAGACTATAGGTGG-3Ј), containing a BglII site at their 5Ј ends (underlined). The PCR product was cloned into the pGEM-T vector (Promega, Madison, WI) and sequenced from both ends, before cloning into the BglII site of the expression vector pCMV-Tag1 (Stratagene, San Diego, CA).
A tagged Fxna construct was generated by PCR-amplifying the Fxna coding region from ovarian RNA with a sense primer (5Ј-GGATCCGCTGCCGCCATGGAGTGG-3Ј) and an antisense primer (5Ј-GATATCATATTACTTGTCGTCATCGTCTTTGTAGTCAAACACAAAGA -GACTATA-3Ј) that contains a FLAG epitope-coding sequence (in italics); BamH1 and EcoRV sequences added to the sense and antisense primers, respectively, are underlined. The resulting construct was ligated into pcDNA-Zeo (Invitrogen).
siRNA synthesis and transfection
Five siRNAs were synthesized by in vitro transcription with T7 RNA polymerase using the Silencer siRNA Construction Kit (Ambion). The siRNAs were named according to their position in the coding region of Fxna mRNA (i.e. starting at 436, 571, 724, 975 and 1239 nt, where ATG=+1).
siRNA 436: sense, 5Ј-AACAGCCTCCACAGAATCTCA-3Ј; antisense, 5Ј- AATGAGATTCTGTGGAGGCTG-3Ј;  siRNA 571: sense, 5Ј-AAGTACGCTGTCCTGGCTAAC-3Ј; antisense, 5Ј-AAGTTAGCCAGGACAGCGTAC-3Ј;  siRNA 724: sense 5Ј-AATGGTGCAGAGGAAAATGTC-3Ј; antisense,  5Ј-AAGACATTTTCCTCTGCACCA-3Ј;  siRNA 975: sense 5Ј-AATCTACAGGGATTTTGGGAA-3Ј; antisense, 5Ј-AATTCCCAAAATCCCTGTAGA-3Ј; and  siRNA 1239: sense, 5Ј-AATAAACTACATGGTGGTAAT-3Ј; antisense,  5Ј-AAATTACCACCATGTAGTTTA-3Ј. The effectiveness of these siRNAs was tested using rat kidney embryonic cells (RK3E) and human 293T cells. The cells were maintained in DMEM (Sigma, St Louis, MO) supplemented with 10% heat-inactivated FBS (HiClone, Logan, UT), and containing penicillin G (100 U/ml; Sigma) and streptomycin sulfate (100 g/ml; Sigma). The medium for 293T cells also contained 50 g/ml gentamycin. Cells were cultured at 37°C under a 5%-CO 2 95%-air atmosphere. Cells were seeded into 6-well plates (3ϫ10 5 cells per well) 24 hours prior to transfection, in antibiotic-free DMEM medium. Each siRNA was transfected (at a 10 nM concentration) using the Gene
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Development 134 (5) Fig. 1 . A novel mRNA differentially expressed in the developing ovary of the rat is also expressed in several other tissues.
(A) Autoradiograph of a sequencing gel showing that the signal intensity of a PCR product (C5-530a2, arrow) derived from the gene differential display amplification of total perinatal rat ovarian RNA is greater in samples from PN-48-hour than F21 ovaries. Each PCR reaction was electrophoresed in duplicate. (B) Northern blot analysis of polyA + RNA extracted from different tissues of 2-day-old female rats identifies a ubiquitous 5.4 kb mRNA species (arrow) and a longer, much less abundant transcript in ovary, kidney and adrenal gland. The cRNA probe used was transcribed from a C5-530a2 cDNA template. Each lane contains 5 g of polyA + RNA. Cyclophilin mRNA (cyclo) detected subsequently on the same blot was used as a control for procedural variability. Migration of the 4.7 and 1.8 kb ribosomal RNA species detected by ethidium bromide staining is indicated on the left side of the blot. Note that cyclophilin mRNA expression is not constant across tissues. Ov, 2-day-old rat ovary; Ut, uterus; Kd, kidney; Ad, adrenal gland; Lv, liver; Pit, pituitary gland; Hy, hypothalamus; Hi, hippocampus; Cc, cerebral cortex.
Eraser Reagent (Stratagene). Cells were harvested 48 hours posttransfection, and total RNA extracted for PCR amplification. The sense primer used (5Ј-CCATCGGCCCCAGGACTA-3Ј) corresponds to nt 361-378 of rat Fxna mRNA (NM_184050), and the antisense primer (5Ј-AACACGAGAAGGGTACGCAATGAC-3Ј) is complementary to nt 1224-1247. As an internal control, we amplified a fragment from rat cyclophilin mRNA using a forward primer (5Ј-ACGCCGCTGTCTCTTTTC-3Ј) corresponding to nt 344-364 of rat cyclophilin mRNA (NM_19533), and a reverse primer (5Ј-CTTGCCACCAGTGCCATTAT-3Ј) complementary to nt 545-565. PCR amplification was performed using HotStart Taq polymerase (Qiagen, Valencia, CA). Equal volumes were electrophoresed on 2% agarose gels stained with ethidium bromide. Gel images were quantitated using Quantity One software (Bio-Rad Laboratories, Hercules, CA). The optical densities of Fxna mRNA were normalized to cyclophilin mRNA.
siRNA specificity
To assess the specificity of LV-sh436 we transfected 293T cells with an expression vector (pCMV-Tag1, Stratagene) encoding either an intact Fxna mRNA or Fxna mRNA carrying silent point mutations of the siRNA target region. The third base of each of two codons in this region was mutated (5Ј-AACAGCCTCCACAGAATaTCt), using the QuickChange XL Site-Directed Mutagenesis Kit (Stratagene). The cells (3ϫ10 5 cells per well in 6-well plates) were transfected with either 70 ng pCMV-Fxna or pCMV-Fxna-Mutated using Lipofectamine 2000 (Invitrogen). Four hours after transfection, the cells were infected with LV-sh436 at a 10:1 virus:cell ratio, and the cells harvested 3 days after infection. Fxna mRNA was measured as outlined above, but cyclophilin mRNA was amplified with a set of primers targeting human cyclophilin (M80524). The sense primer (5Ј-GGGAAGTCCATCTACGGA-3Ј) corresponds to nt 432-450 of human cyclophilin mRNA, and the antisense primer (5Ј-ACATGCTTGCC ATCCAAC-3Ј) is complementary to nt 571-599.
Design and cloning of shRNA-producing cassettes
Delivery of siRNAs via lentiviruses was carried out as described (Tiscornia et al., 2003) . A cassette derived from the vector pSilencer 1.0-U6 (Ambion) was cloned into the 3Ј long terminal repeat (3Ј-LTR; BbsI site) of a lentiviral vector modified from that described by others (Follenzi et al., 2000) . In this cassette, transcription of siRNAs is directed by the mouse RNA Polymerase III U6 promoter. In our plasmid, termed LV-EGFP, the original PGK promoter driving expression of an enhanced green fluorescent protein 947 RESEARCH ARTICLE Aminopeptidases and ovarian development (EGFP) (Follenzi et al., 2000) was replaced by a cytomegalovirus (CMV) promoter. The DNA sequence encoding the most potent siRNA (siRNA 436) was cloned into the ApaI-EcoRI sites of the multiple cloning site of the U6 cassette (see Fig. S1 in the supplementary material). We refer to this construct as LV-sh436. A DNA fragment encoding siRNA 436 with nucleotide mismatches (LV-sh436 mism, 5Ј-CAGGCTCGAC AGTATC -TGATTCAAGAGATCAGATACTGTCGAGCCTGTTTTTT-3Ј; the hairpin loop and the polyT sequences are in italics; mismatches are underlined) was similarly cloned.
The lentiviral gene delivery system
This system, which represents a prototype of third-generation, safe, replication-defective lentiviral vectors (Dull et al., 1998; Follenzi et al., 2000) , consists of two packaging plasmids (pMDLgpRRE, pRSV-Rev), an envelope plasmid (pMD.G) and a lentiviral vector plasmid (pLV, the 'delivery vector') that encodes an EGFP marker. The 3Ј-LTR is self-inactivating. Recombinant lentiviruses were produced by cotransfecting the four plasmids into 293T cells using the calcium phosphate method (Dull et al., 1998) . The medium containing infectious viral particles was collected 24 and 48 hours after transfection and filtered through a 0.22 m membrane (Steriflip; Millipore, Bedford, MA). Lentiviruses were concentrated by ultracentrifugation (2 hours, 53,000ϫg) and purified through 20% sucrose (2 hours, 45,000ϫg) (Tiscornia et al., 2003) . Lentivirus titer was determined by flow cytometry (FACScalibur; BD Biosciences, San Jose, CA) using serial dilutions of the virus, and EGFP as the marker. The titer is expressed as transducing units (TU) per ml.
Interferon-like responses
To rule out non-specific mRNA degradation resulting from activation of the interferon system, semi-quantitative PCR was used to measure the mRNA content of 2Ј-5Ј oligoadenylate synthase (Oas1), a major interferon target gene (Bridge et al., 2003) , in untreated cultured ovaries and ovaries treated with LV-sh436, LV-sh436 mism or LV-EGFP. The primers used to detect Oas1 were: sense, 5Ј-TACAATCCTGATCCC -AAGA-3Ј corresponding to nt 538-559 of rat Oas1 mRNA (NM_138913); and antisense, 5Ј-GAGCTCCGTGAAGCAGGTAGA-3Ј complementary to nt 613-633.
RESEARCH ARTICLE Development 134 (5) is 211 nt in length, of which 158 nt correspond to transcribed vector sequences. The mRNA species protected by probe A, and the cyclophilin cRNA probe, are arrowed. MM, molecular weight markers ( 32 P-labeled RNA ladder); UP, undigested probe; DP, digested probe; A, adult ovaries. Right panel is a densitometric analysis of the changes in C5-530a2 mRNA levels detected by RNase-protection assay. RNA abundance is expressed as arbitrary units (AU) calculated using the individual C5-320a2/cyclophilin mRNA ratios from each sample. **, P<0.02, 48 hour group versus all other groups. Bars are mean values for each group and vertical lines represent s.e.m. (C) The same RNase-protection assay analysis as in B, but using probe B and samples pooled from selected developmental ages. Probe B consists of 492 nt, of which 406 correspond to transcribed vector sequences. 
Organ culture
The ovaries from newborn rats (on day of birth), were cultured as described (George and Ojeda, 1987) . One ovary from each animal was treated for 4 days with LV-EGFP and the contralateral ovary with LV-sh436, each at 4ϫ10 6 TU per well. Some ovaries (two pools containing three glands per pool) were treated with LV-sh436 mism.
Proliferation and apoptosis
To assess proliferation, newborn rat ovaries were cultured as described above, and the culture medium supplemented with 100 M bromodeoxyuridine (BrdU; Roche Diagnostics, Indianapolis, IN) 24 hours before termination of the culture. Thereafter, the ovaries were fixed in Kahle's fixative (Hirshfield and DeSanti, 1995) , embedded in paraffin and sectioned at 6 m. BrdU immunohistochemistry was performed using a monoclonal antibody (Mab-2531, 1:1000; Sigma) and the reaction was developed with DAB-nickel chloride (Dees et al., 1995) . Ovary sections were imaged on a Marianas Imaging Workstation using Slidebook (Intelligent Imaging, Denver, CO), and a 10ϫ NA 0.5 objective. BrdUpositive cells were counted using Metamorph (Universal Imaging, West Chester, PA) in 30 identical rectangles (70ϫ52 pixels) corresponding to an area of 1456 m 2 , each uniformly distributed in a random fashion over four sections from each group.
Apoptotic ovarian cells were detected in 14 m cryostat sections using the TUNEL assay according to the manufacturer's specifications (Roche Diagnostics).
Follicular development
Cultured ovaries were fixed in Kahle's fixative, embedded in paraffin, serially sectioned at 6 m, and stained with Weigert's iron Hematoxylin and counterstained with picric acid-Methyl Blue (Dissen et al., 2001) . Every third section was imaged on a Zeiss Axioplan (Carl Zeiss, Jenna, Germany), using a CoolSnap camera (Roper Scientific, Stillwater, MN). Follicles were counted using the manual count feature of MetaMorph (Universal Imaging, West Chester, PA) as reported (Dissen et al., 2001; Paredes et al., 2004) .
Immunohistofluorescence-confocal microscopy
Ovarian cells infected by the lentivirus were visualized by immunofluorescence in 14 m frozen sections using an anti-EGFP polyclonal antibody (Molecular Probes, Eugene, OR; 1:800, overnight incubation at 4°C). Immunoreactivity was developed using an Alexa 488-conjugated donkey anti-rabbit gamma globulin antibody (Molecular Probes; 1:200). Control sections were incubated without primary antibody. Images were acquired as previously reported (Dissen et al., 2001) . Cell nuclei were stained with Hoescht 33258 (Invitrogen; 0.1 g/ml KPBS for 1 minute after completion of the immunohistochemical reactions).
To determine the intracellular localization of Fxna, COS-7 cells (1.5ϫ10 5 cells per well in 6 well plates, i.e. 15,000 cells/cm 2 ) were transfected with either 650 ng per well of Fxna-Flag-pcDNA or the empty vector (pcDNA3.1 Zeo) using Lipofectamine 2000. Twenty-four hours later the cells were fixed in acetone (1 minute at -20°C). Fxna-Flag was detected with an anti-Flag monoclonal antibody (M2, Sigma) at 1:1000 dilution, and the reaction was developed using an Alexa 488-conjugated donkey anti-mouse gamma globulin antibody (1:500). To visualize the endoplasmic reticulum, we used a rabbit polyclonal antibody (sc-20132, Santa Cruz; 1:250) against oxidoreductase-protein disulfide isomerase (PDI), an endoplasmic reticulum-specific protein. The PDI reaction was developed using Alexa 594-conjugated donkey anti-rabbit gamma globulin antibody (1:500). Cell nuclei were stained with Hoescht.
Statistical analysis
Comparisons between two groups were performed using either the unpaired (cell transfection studies) or paired (organ culture, morphometric studies) Student's t-test. Sequence comparisons were performed using BlastP (Altschul et al., 1990 ) against the non-redundant protein sequence database at NCBI (Benson et al., 2006) , and using FastA (Lipman and Pearson, 1985) against the peptidase sequence collection compiled by the MEROPS database team (Rawlings et al., 2006) .
RESULTS
A novel mRNA is differentially expressed in the developing rat ovary Because folliculogenesis in the rat is initiated 48 hours after birth (Malamed et al., 1992; Rajah et al., 1992) , we compared the expression profiles of RNA extracted from pools of F21 ovaries with those derived from ovaries dissected at PN 48 hours, using the technique of gene differential display (Martin and Pardee, 1999 ). An ␣-33 P-ATP-labeled band (C5-530a2) of approximately 300 bp (arrow in Fig. 1A) showing increased intensity at PN 48 hours was selected for further analysis. The PCR product showed strong similarity to a mouse hypothetical gene (BC031519) located on chromosome 19, predicted to encode a 3.3 kb mRNA species and a protein of 317 amino acids.
C5-530a2 mRNA is larger than the predicted mRNA and is expressed in several tissues of 2-day-old rats The size of the predicted C5-530a2 mRNA was estimated by northern blot hybridization using a cRNA probe transcribed from C5-530a2 cDNA. The mRNA is widely expressed in rat tissues (Fig.  1B) , with the greatest abundance seen in ovary, kidney and two areas of the brain (hypothalamus and hippocampus). Contrary to the predicted mRNA size of 3.3 kb, the northern blot showed the 951 RESEARCH ARTICLE Aminopeptidases and ovarian development existence of a major mRNA species of 5.4 kb. The heavier, but minor, hybridizing species observed in ovary, kidney and adrenal gland may correspond to a transcript(s) resulting from the use of alternative transcription start sites or alternative polyadenylation signals. Because no hybridizing species smaller than 5.4 kb was detected, we conclude that the C5-530a2 mRNA is larger than the size predicted by computational analysis.
The C5-530a2 locus encodes a 5095 nt mRNA species whose expression increases at the time of ovarian follicle assembly The region 5Ј to the sequence reported for BC031519 contains an in-frame ATG site 1743 nt upstream from the predicted ATG. By comparing the sequence of PCR products derived from the amplification of reverse-transcribed ovarian RNA with the genomic sequence of contig AC096329, we determined that the C5-520a2 gene consists of 15 exons spread over 34,154 nt in chromosome 1 (see www.ensembl.org, June 2006). The mRNA coding region consists of 2697 nt, which would encode a predicted protein of 898 amino acids (Fig. 2) .
RNA from ovaries at different developmental phases was analyzed by RNase-protection assay using two cRNA probes. Probe A (289 nt) corresponds to the C5-530a2 sequence obtained by gene differential display; probe B (406 nt) recognizes a sequence spanning the originally predicted ATG site in BC031519 (Fig. 3A) . Consistent with the gene differential display results, C5-530a2 mRNA abundance detected with probe A increased significantly (P<0.02) at PN 48 hours, decreasing thereafter (P<0.02) to lower levels in adult ovaries (Fig. 3B) . A similar profile was observed when probe B was hybridized to a pool of RNA samples from selected ages (Fig. 3C) . Probe B recognized a single mRNA species, suggesting the absence of a C5-530a2 mRNA variant conforming to the mRNA predicted in BC031519. Based on these observations, we named the new gene (NM_184050) Fxna (for Felix-ina).
Fxna is a transmembrane peptidase of the M28 family localized to the endoplasmic reticulum
The predicted Fxna protein sequence is similar to members of peptidase family M28 (Rawlings and Barrett, 1995) (Fig. 4) . Fig. 5 depicts the nucleotide sequence of Fxna and its predicted amino acid composition, showing the peptidase unit (underlined), the catalytic residues Asp201 and Glu245 (circled), and the metal ligand residues His199, Asp211, Glu246, Glu272 and His 348 (in squares).
Further analysis of the protein (http://www.cbs.dtu.dk/ services/SignalP) predicted the absence of a canonical signal peptide. Thus, it is unlikely that Fxna is a secreted protein, a conclusion supported by a second analysis using a different software package (http://www.cbs.dtu.dk/services/SecretomeP). Instead, Fxna appears to be embedded into cellular membranes, via eight transmembrane domains located towards its C-terminus (Fig. 6A) . The peptidase domain of Fxna is located toward the N-terminus (amino acid residues 163-393), a portion of the protein predicted to be localized on the external surface of cellular membranes (http://www.cbs.dtu.dk).
To identify the cellular membrane where Fxna is localized, we transfected COS-7 cells with Fxna-Flag and examined the cells by immunohistofluorescence-confocal microscopy using antibodies against the Flag epitope and against PDI, an
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Development 134 (5) endoplasmic reticulum (ER)-specific marker. Fxna immunoreactivity colocalized with PDI ( Fig. 6B-D) , indicating that under basal conditions (i.e. in the absence of experimentally induced ligand-dependent activation of cell membrane receptors), Fxna is associated with ER membranes.
Fxna is selectively expressed in granulosa cells of the rat ovary
Ovaries collected 48 hours after birth were used to identify by in situ hybridization the cellular sites of Fxna mRNA expression in the rat ovary, using cRNA probe B labeled with 35 S-UTP. Fxna mRNA was abundantly expressed in newly formed ovarian follicles (Fig. 7A) . Higher magnification revealed that Fxna mRNA was present in cells surrounding oocytes, i.e. granulosa cells (Fig. 7B ), but not in oocytes (arrows). Examination of ovaries at PN-day 21 confirmed the selective localization of Fxna mRNA to ovarian follicles (Fig.  7C,D) , and showed that atretic antral follicles do not contain Fxna mRNA (arrows). Within both preantral and antral follicles, Fxna mRNA was found only in granulosa cells (Fig. 7E,F) , without detectable hybridization in oocytes (arrows).
Lentiviral-mediated delivery of siRNAs to the ovary decreases Fxna mRNA levels without triggering an interferon response
To determine the role of Fxna in the development of the ovary we employed an siRNA-mediated gene knock-down approach. Of five siRNAs tested, one (siRNA 436) silenced Fxna expression by more than 80% in the rat kidney cell line RK3E that expresses Fxna mRNA (Fig. 8A) . None of the siRNAs tested showed offtarget effects, as indicated by the unchanging levels of cyclophilin mRNA in the treated cells in comparison with untreated controls (Fig. 8A) . After determining the biological potency and specificity of siRNA 436, the DNA sequence encoding siRNA 436 was cloned into pLV to generate viral particles producing shRNA.
Using this construct, a 'rescue' experiment was performed using an Fxna mRNA in which the region targeted by siRNA 436 carries silent nucleotide substitutions. 293T cells were transfected with expression vectors encoding the wild-type or the mutated Fxna mRNA form, plus the virus producing siRNA 436 (LVsh436), and were cultured for 4 days. LV-sh436 suppressed wildtype Fxna mRNA expression, but failed to decrease mutant Fxna mRNA levels (Fig. 8B) , demonstrating the specificity of the siRNA effect.
To evaluate the ability of LV-sh436 to decrease Fxna gene expression in the ovary, 1-day-old rat ovaries were placed in organ culture and treated for 4 days with LV-sh436 (4ϫ10 6 TU per well, in 750 l of medium). Fxna mRNA abundance was reduced by more than 90% in the LV-sh436-treated group as compared with LV-EGFP-treated controls (Fig. 9A ). Ovaries treated with LVsiRNA 436 mism had Fxna mRNA levels indistinguishable from those seen in LV-EGFP-treated controls (LV-siRNA mism levels were 98.5% of those of the LV-EGFP group, data not shown). Despite this ineffectiveness we did not use this mutated siRNA further to avoid potential off-site effects resulting from the hypothetical ability of mismatched siRNAs to inhibit the translation of an unrelated gene(s) via a microRNA-like action (see the symposium on Understanding the RNAissance at www.nature.com/horizon).
A major difficulty encountered when using siRNAs (Sledz et al., 2003) and/or their delivery vectors (Bridge et al., 2003) is activation of the interferon system (Bridge et al., 2003; Sledz et al., 2003) . To address this issue we adopted a recommended strategy (Bridge et al., 2003) and measured the mRNA encoded by the major interferon target gene 2Ј-5Ј oligoadenylate synthase (Oas1) (Pebernard and Iggo, 2004; Samuel, 2001) in the same samples used to validate the effect of LV-sh436 on Fxna mRNA levels. Oas1 mRNA levels were similar in ovaries treated with LV-EGFP, LV-sh436 and LV-sh436 mism (Fig. 9B) , indicating the absence of an interferon response in the Fxna-knock-down ovaries.
Fxna deficiency disrupts follicular development and alters the structural organization of the ovary
To determine the cellular sites of LV expression, newborn rat ovaries were cultured for 4 days in the presence of LV-EGFP (4ϫ10 6 TU per well in 750 l of medium), before immunohistochemical detection of EGFP. As shown in Fig. 9C,D , infection was widespread, with EGFP-immunoreactive material observed in both somatic cells and oocytes. Infection of newborn ovaries with LV-sh436 for 4 days severely compromised the follicular structure as compared with that observed in control, LV-EGFP infected glands (Fig. 9E,F) . The LV-
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Aminopeptidases and ovarian development sh436-infected ovaries exhibited aggregates of somatic cells excluding oocytes, and oocytes not encapsulated by granulosa cells (Fig. 9G,H) .
To evaluate morphologically the consequences of Fxna deficiency on ovarian development, newborn rat ovaries were treated as above before conducting histopathologic and morphometric analyses of the glands. The ovaries treated with LV-EGFP showed an architecture typical of newborn ovaries grown in tissue culture (Kezele and Skinner, 2003) , i.e. with many primordial follicles, but also showing an abundance of primary follicles (Fig. 10A,C) . By contrast, the ovaries treated with LV-sh436 exhibited areas of striking immaturity (Fig. 10B ) and overall structural disorganization characterized by solitary follicles containing up to four oocytes, nests of oocytes not associated with somatic cells, and aggregates of somatic cells not associated with oocytes (Fig. 10D) . The number of 'naked' oocytes per ovary was similar in Fxna-knock-down ovaries and LV-EGFPtreated controls (Fig. 10E, left panel) , but Fxna-deficient ovaries exhibited a marked (P<0.01) decrease in the total number of follicles per ovary (Fig. 10E, right panel) . A more detailed analysis of the follicle populations affected revealed that all categories of follicles (primordial, primary and secondary) were significantly reduced in Fxna-deficient ovaries (Fig. 10F) . These results indicate that the deficiency in follicular formation seen in the absence of Fxna is not secondary to a primary loss of oocytes.
The effects of Fxna deficiency on ovarian histogenesis are not related to alterations in either apoptotic or proliferative rates of ovarian cells To determine if the alterations in ovarian histogenesis observed in Fxna-deficient ovaries were due to abnormal proliferation of somatic cells or somatic cell/oocyte death, we performed apoptosis and proliferation assays in LV-EGFP and LV-sh436-treated ovaries. No differences in the number of apoptotic cells per ovary as detected by TUNEL, or in the incorporation of BrdU into cell nuclei as detected by immunohistochemistry, were apparent between the two groups (data not shown).
DISCUSSION
The present study identifies a novel, hereto hypothetical gene as an important constituent of the regulatory machinery controlling definitive ovarian histogenesis. This gene, which we have termed Fxna, is selectively expressed in the granulosa cell compartment of ovarian follicles. Fxna mRNA is not only abundant in newly formed primordial follicles, but also in granulosa cells throughout the natural history of follicular growth, including the preovulatory antral stage. Noticeably, whereas the majority, if not all, preantral follicles express Fxna, a subpopulation of antral follicles with atretic features do not, suggesting that such follicles are in a RESEARCH ARTICLE Development 134 (5) functional stage associated with loss of Fxna functions. The possibility that Fxna abundance is reduced in follicles undergoing atresia, a process initiated in earnest at the time of antral formation (Hsueh et al., 1994) , deserves further consideration. Analysis of its structural domains revealed that Fxna is a metallopeptidase that belongs to peptidase family M28 (Rawlings and Barrett, 1995) . The structural characteristics of Fxna predict its existence as a membrane-bound protein, and our results demonstrate that in contrast to most peptidases expressed in reproductive organs (Fujiwara et al., 1999) , Fxna is localized to the ER instead of the cell membrane. Previously described ER peptidases include endoplasmic reticulum aminopeptidase 1 (ERAP1) (Fruci et al., 2006) , the related aminopeptidase leukocyte-derived arginine aminopeptidase (L-RAP, also called ERAP2) (Saveanu et al., 2005; Tanioka et al., 2003) , and vitellogenic carboxypeptidase-like protein (Harris et al., 2006) . The presence in Fxna of up to eight putative transmembrane domains resembles the hydropathy profile of site-2 protease (S2P), a zinc metallo-aminopeptidase required for the intramembranous proteolysis of sterol-regulatory-element-binding proteins (SREBPs) (Rawson et al., 1997) . S2P is embedded in the ER via 5 transmembrane domains and releases the N-terminal domain of SREBPs within the ER membrane (Zelenski et al., 1999) .
Peptidases bound to intracellular membranes may have fascinating functional properties as shown by the insulin-regulated aminopeptidase (IRAP), which is bound to intracellular membranes under basal conditions, but redistributes to the cell membrane in response to insulin stimulation (Keller, 2003) . In type 2 diabetes, insulin action is impaired and the translocation of IRAP to the cell membrane fails to occur, suggesting that the absence of IRAPmediated peptide processing on the cell membrane is an intrinsic component of this pathology. Although our results do not identify the mode of action of Fxna, they do demonstrate that Fxna is essential for the normalcy of definitive ovarian histogenesis. Silencing the Fxna gene strikingly disrupts ovarian structural organization. In Fxna-deficient ovaries, both the rate of follicle assembly and initiation of follicle growth are compromised, without detectable prior loss of oocytes. An even more remarkable feature is a widespread loss of somatic germ cell organization. Pregranulosa cells appear to encircle more than one oocyte, and many oocytes remain clustered in isolation without having been infiltrated by somatic cells, as would normally occur during follicular formation (Hirshfield, 1991) .
Very few substrates for metallopeptidases have been identified. We do not know at present which proteins are hydrolyzed by Fxna. Because of its intracellular localization, Fxna might be necessary for the correct processing of proteins involved in cell signaling (Wolfe and Kopan, 2004) and/or transcriptional control (Rawson et al., 1997) . Alternatively, it may act as a general degrading protease of transmembrane protein precursors. Nevertheless, the alterations in structural organization resulting from the loss of Fxna function in the ovary argue against the latter possibility, and suggest that systems affected by the deficiency may be those cell-to-cell communication pathways required for definitive ovarian histogenesis. The two major morphogenic signaling complexes required for the organization of the very processes affected by Fxna deficiency are the Jagged-Notch (Artavanis-Tsakonas et al., 1999; Lai, 2004) and the Wnt-Frizzled (Cadigan and Nusse, 1997; Miller et al., 1999) signaling systems. Of note, both Notch2 and Frizzled1 receptors are expressed in granulosa cells throughout preantral development (Johnson et al., 2001; Richards et al., 2002) , and in both cases loss of function results in abnormalities similar to those seen in Fxna-deficient ovaries (Hahn et al., 2005; Vainio et al., 1999) . Should Fxna be involved in processing any of the basic and/or associated components of these systems, one would have to assume that it acts early in the processing pathway, as a proteolytic event that precedes the transport of such target proteins to the Golgi apparatus for covalent modifications and intracellular targeting.
In summary, our results identify a new regulatory system that operates in somatic granulosa cells to control ovarian development, and which appears to be required for proper structural organization of the ovary. The cellular systems targeted by the action of Fxna remain to be identified.
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